These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6811359)

  • 1. Increased level of ribonucleotide reductase and associated resistance to aphidicolin in mouse FM3A cell mutants selected for simultaneous resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.
    Iwata K; Ayurawa D; Seno T
    Gan; 1982 Apr; 73(2):167-74. PubMed ID: 6811359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual sensitivity to bleomycin and joint resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine of mouse FM3A cell mutants with altered ribonucleotide reductase and thymidylate synthase.
    Ayusawa D; Iwata K; Seno T
    Cancer Res; 1983 Feb; 43(2):814-8. PubMed ID: 6184158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of ribonucleotide reductase in aphidicolin-resistant mutants of mouse FM3A cells with associated resistance to arabinosyladenine and arabinosylcytosine.
    Ayusawa D; Iwata K; Seno T
    Somatic Cell Genet; 1981 Jan; 7(1):27-42. PubMed ID: 6784257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level of aphidicolin resistance with multiple mutations in mouse FM3A cell mutants.
    Ito M; Matsuhashi M; Seno T; Ayusawa D
    Somat Cell Mol Genet; 1990 Sep; 16(5):443-50. PubMed ID: 2122528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ; Kufe DW
    Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity.
    Fridland A
    Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of aphidicolin-resistant CHO cells with altered levels of ribonucleotide reductase.
    Sabourin CL; Bates PF; Glatzer L; Chang CC; Trosko JE; Boezi JA
    Somatic Cell Genet; 1981 Mar; 7(2):255-68. PubMed ID: 6794165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
    Satyamoorthy K; Deshpande SS; Chitnis MP
    Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL; Shaddix SC; Brockman RW; Bennett LL
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese hamster ovary cell mutants resistant to DNA polymerase inhibitors. I. Isolation and biochemical genetic characterization.
    Vishwanatha JK; Mishra NC
    Mol Gen Genet; 1985; 200(3):393-400. PubMed ID: 3930921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese hamster ovary cell mutants resistant to DNA polymerase inhibitors. II. Segregational analysis and DNA transfection of the aphr gene.
    Vishwanatha JK; Mishra NC
    Mol Gen Genet; 1985; 200(3):401-6. PubMed ID: 3930922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.
    Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL; Cory JG
    Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
    Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aphidicolin sensitivity of variant 3T6 cells selected for changes in ribonucleotide reductase.
    Nicander B; Reichard P
    Biochem Biophys Res Commun; 1981 Nov; 103(1):148-55. PubMed ID: 6797427
    [No Abstract]   [Full Text] [Related]  

  • 16. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response of human and rodent cell lines to chemical inhibition of the repair of potentially lethal damage.
    Little JB; Ueno AM; Dahlberg WK
    Radiat Environ Biophys; 1989; 28(3):193-202. PubMed ID: 2508186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and preliminary characterization of 9-beta-d-arabinofuranosyladenine-resistant mutants of baby hamster cells.
    Chan VL; Juranka P
    Somatic Cell Genet; 1981 Mar; 7(2):147-60. PubMed ID: 6974904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.
    Parker WB; Bapat AR; Shen JX; Townsend AJ; Cheng YC
    Mol Pharmacol; 1988 Oct; 34(4):485-91. PubMed ID: 3050447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aphidicolin-resistant mutator strains of mouse teratocarcinoma.
    Aizawa S; Loeb LA; Martin GM
    Mol Gen Genet; 1987 Jun; 208(1-2):342-8. PubMed ID: 3112523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.